Cyclovirobuxine D Ameliorates Experimental Diabetic Cardiomyopathy by Inhibiting Cardiomyocyte Pyroptosis via NLRP3 in vivo and in vitro

Diabetic cardiomyopathy (DCM) is one of the common complications of diabetic patients, which can induce myocardial hypertrophy, cardiac fibrosis, and heart failure. Growing evidence has shown that the occurrence and development of DCM are accompanied by pyroptosis which is an NLRP3-mediated intense...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ge, Fu, Lingyun, Xu, Yini, Tao, Ling, Guo, Ting, Fang, Guanqin, Zhang, Guangqiong, Wang, Shengquan, Qin, Ti, Luo, Peng, Shen, Xiangchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294384/
https://www.ncbi.nlm.nih.gov/pubmed/35865939
http://dx.doi.org/10.3389/fphar.2022.906548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294384/
https://www.ncbi.nlm.nih.gov/pubmed/35865939
http://dx.doi.org/10.3389/fphar.2022.906548

Ejemplares similares